Global Empty IV Bags Market Outlook, 2031

The global empty IV bags market has emerged as a critical segment within the medical devices industry, providing essential containers for the delivery of intravenous fluids, medications, and nutritional solutions to patients in healthcare settings. Empty IV bags are sterile, single-use containers that are filled with intravenous solutions at the point of use or in pharmaceutical manufacturing facilities, enabling the safe and controlled administration of fluids and medications. The market encompasses a range of products including bags manufactured from PVC, polypropylene, copolyester ether, ethylene-vinyl acetate (EVA), and other medical-grade materials that ensure product safety, flexibility, and compatibility with various IV solutions. The market is driven by the increasing prevalence of chronic diseases requiring intravenous therapy, the growing number of surgical procedures, the expanding healthcare infrastructure in developing countries, and the rising demand for home healthcare and outpatient infusion services. The growing emphasis on patient safety and infection prevention is driving demand for sterile, single-use IV bags that reduce cross-contamination risks.

According to the research report "Global Empty IV Bags Market Outlook, 2031," published by Bonafide Research, the global Empty IV Bags market was valued at USD 4.5 Billion in 2025. The market is experiencing steady growth driven by the increasing global healthcare expenditure, the expanding demand for intravenous therapy, and the growing emphasis on patient safety and infection prevention. The shift toward non-PVC materials, including polypropylene and EVA, is accelerating as healthcare providers seek to address phthalate exposure concerns and meet regulatory requirements. The increasing adoption of ready-to-use and pre-filled IV bags is creating new market opportunities. The expansion of home healthcare and outpatient infusion services is driving demand for portable, easy-to-use IV bag solutions. Manufacturers are increasingly focusing on developing IV bags with enhanced safety features including integrated ports, tamper-evident seals, and antimicrobial coatings.

Drivers Rising prevalence of chronic diseases requiring intravenous therapy: The increasing prevalence of chronic conditions including cancer, diabetes, kidney disease, and gastrointestinal disorders requiring intravenous therapy is a primary driver for the empty IV bags market. The growing patient population requiring IV fluids and medications drives sustained demand for IV bags.

Growing surgical volumes and healthcare infrastructure expansion: The increasing number of surgical procedures worldwide is driving demand for IV bags for fluid administration during surgery. Healthcare infrastructure expansion in developing countries is creating new demand for IV bags in newly established hospitals and clinics.

Challenges Phthalate exposure concerns with PVC bags: Concerns about phthalate leaching from PVC IV bags, particularly DEHP, have raised safety concerns and regulatory scrutiny. The shift toward non-PVC materials requires significant investment in manufacturing process changes and material qualification.



Regulatory requirements and quality standards: IV bags are subject to stringent regulatory requirements for safety, sterility, and performance. Meeting regulatory standards across multiple regions requires significant investment in quality systems and testing.

Trends Shift toward non-PVC and phthalate-free materials: The growing regulatory pressure and safety concerns regarding phthalate exposure are driving the shift toward non-PVC materials including polypropylene, EVA, and copolyester ether. Manufacturers are developing phthalate-free IV bag solutions for healthcare providers.

Development of integrated safety features: IV bag manufacturers are developing products with integrated safety features including tamper-evident seals, antimicrobial ports, and needle-free access systems to enhance patient safety and reduce infection risks.

The market is segmented by product into PVC, polypropylene, copolyester ether, ethylene-vinyl acetate (EVA), and others, with PVC currently holding a significant market share while non-PVC materials represent the fastest-growing segment. PVC represents a significant segment within the empty IV bags market, driven by its established manufacturing processes, cost-effectiveness, and proven performance in IV fluid delivery applications. PVC IV bags have been the industry standard for decades, with well-established supply chains and regulatory acceptance. However, the PVC segment is facing pressure from phthalate exposure concerns and regulatory actions restricting DEHP-containing medical devices in some regions. Polypropylene represents a growing segment, offering excellent clarity, flexibility, and compatibility with a wide range of IV solutions. Polypropylene bags are free from phthalate plasticizers, addressing safety concerns associated with PVC. The increasing regulatory preference for non-PVC materials is driving polypropylene adoption. Ethylene-vinyl acetate (EVA) represents a significant segment, offering excellent flexibility, clarity, and compatibility with IV solutions. EVA is widely used in specialty IV applications where high clarity and flexibility are required. Copolyester ether represents an emerging segment, offering superior clarity and flexibility without the need for plasticizers. The others segment includes multilayer bags and specialty materials for specific applications.

North America leads the global empty IV bags market, driven by advanced healthcare infrastructure, high surgical volumes, and early adoption of non-PVC IV bag technologies. North America holds the dominant position in the global empty IV bags market, with the United States serving as the primary growth engine. The region's leadership is supported by advanced healthcare infrastructure, high surgical volumes, and significant investment in healthcare technology. The presence of major IV bag manufacturers including Baxter, Becton Dickinson, and Fresenius Kabi ensures product availability and innovation. The growing emphasis on patient safety and the shift toward non-PVC materials is driving product innovation and replacement cycles. The region's strict regulatory framework for medical devices ensures high quality standards and product safety. The large patient population requiring intravenous therapy and the high number of surgical procedures drive sustained demand. The expansion of outpatient care and home healthcare services is creating new demand for IV bag solutions. Canada follows similar trends with a mature healthcare system and growing adoption of advanced IV bag technologies. The region's combination of healthcare infrastructure, regulatory framework, and innovation ensures continued market leadership through the forecast period.

In 2025: Major IV bag manufacturers expanded non-PVC product lines, addressing growing demand for phthalate-free and environmentally friendly IV bag solutions.

In 2025: IV bags with integrated safety features including tamper-evident seals and antimicrobial ports gained market traction.

In 2024: Manufacturers invested in production capacity expansion to meet growing demand from expanding healthcare markets in developing regions.

In 2024: New material technologies for IV bags were developed, offering improved clarity, flexibility, and compatibility with sensitive medications.


Considered in this report
• Historic Year: 2020
• Base Year: 2025
• Estimated Year: 2026
• Forecast Year: 2031

Aspects covered in this report
• Global Empty IV Bags Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• PVC
• Polypropylene
• Copolyester Ether
• Ethylene-Vinyl Acetate (EVA)
• Others